File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.12703/P5-7
- Scopus: eid_2-s2.0-84876774488
Supplementary
-
Citations:
- Scopus: 0
- Appears in Collections:
Article: Perioperative cardioprotection
Title | Perioperative cardioprotection |
---|---|
Authors | |
Issue Date | 2013 |
Citation | F1000Prime Reports, 2013, v. 5, article no. 7 How to Cite? |
Abstract | Although anaesthesia itself is now very safe, perioperative cardiac complications during non-cardiovascular surgery are a major cause of morbidity and mortality, because of the increasingly high underlying prevalence of cardiovascular disease. Fortunately, although there is no “magic bullet”, pharmacological intervention can reduce the risk. In particular, current evidence strongly supports the use of aspirin and statins. Beta blockers may also be beneficial in higher risk groups but need to be titrated to effect, and their use requires careful consideration because of adverse effects in these patients. |
Persistent Identifier | http://hdl.handle.net/10722/184449 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Leung, KMM | en_US |
dc.contributor.author | Irwin, MG | en_US |
dc.date.accessioned | 2013-07-15T09:46:35Z | - |
dc.date.available | 2013-07-15T09:46:35Z | - |
dc.date.issued | 2013 | en_US |
dc.identifier.citation | F1000Prime Reports, 2013, v. 5, article no. 7 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/184449 | - |
dc.description.abstract | Although anaesthesia itself is now very safe, perioperative cardiac complications during non-cardiovascular surgery are a major cause of morbidity and mortality, because of the increasingly high underlying prevalence of cardiovascular disease. Fortunately, although there is no “magic bullet”, pharmacological intervention can reduce the risk. In particular, current evidence strongly supports the use of aspirin and statins. Beta blockers may also be beneficial in higher risk groups but need to be titrated to effect, and their use requires careful consideration because of adverse effects in these patients. | - |
dc.language | eng | en_US |
dc.relation.ispartof | F1000Prime Reorts | en_US |
dc.title | Perioperative cardioprotection | en_US |
dc.type | Article | en_US |
dc.identifier.email | Leung, KMM: meil@hku.hk | en_US |
dc.identifier.email | Irwin, MG: mgirwin@hku.hk | en_US |
dc.identifier.authority | Irwin, MG=rp00390 | en_US |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.12703/P5-7 | - |
dc.identifier.scopus | eid_2-s2.0-84876774488 | - |
dc.identifier.hkuros | 216271 | en_US |
dc.identifier.volume | 5 | en_US |
dc.identifier.spage | article no. 7 | en_US |
dc.identifier.epage | article no. 7 | en_US |